EUVIMEDEUVIMED entdecken
Crossref

The Association Between Pri-Mir-34b/Crs4938723 Polymorphism and Risk of Hepatocellular Carcinoma in Egyptian Patients

Alyaa Sabry Abdelwahed, Naglaa Allam Ahmed Allam, Asmaa Ibrahim Elsayed Gomaa, Sameera Ezzat Aboelkheir, Heba Samy Mohamed Ghanem, Nehal Hamdi Ibrahim

Al-Azhar International Medical Journal · 31.07.2025 · 2025 (7) · 18-23

DOI: 10.21608/aimj.2025.446630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al-Azhar International Medical Journal, online erschienen am 31.07.2025. Verfasst von Alyaa Sabry Abdelwahed und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Abdelwahed, A. S., Allam, N. A. A., Gomaa, A. I. E., Aboelkheir, S. E., Ghanem, H. S. M., & Ibrahim, N. H. (2025). The Association Between Pri-Mir-34b/Crs4938723 Polymorphism and Risk of Hepatocellular Carcinoma in Egyptian Patients. Al-Azhar International Medical Journal, 2025(7), 18-23. https://doi.org/10.21608/aimj.2025.446630

Vancouver

Abdelwahed AS, Allam NAA, Gomaa AIE, Aboelkheir SE, Ghanem HSM, Ibrahim NH. The Association Between Pri-Mir-34b/Crs4938723 Polymorphism and Risk of Hepatocellular Carcinoma in Egyptian Patients. Al-Azhar International Medical Journal. 2025;2025(7):18-23. doi:10.21608/aimj.2025.446630

BibTeX
@article{Abdelwahed2025,
  author = {Abdelwahed, Alyaa Sabry and Allam, Naglaa Allam Ahmed and Gomaa, Asmaa Ibrahim Elsayed and Aboelkheir, Sameera Ezzat and Ghanem, Heba Samy Mohamed and Ibrahim, Nehal Hamdi},
  title = {The Association Between Pri-Mir-34b/Crs4938723 Polymorphism and Risk of Hepatocellular Carcinoma in Egyptian Patients},
  journal = {Al-Azhar International Medical Journal},
  year = {2025},
  volume = {2025},
  number = {7},
  pages = {18--23},
  doi = {10.21608/aimj.2025.446630}
}
Kostenlos starten →